Omega Healthcare Investors Inc (OHI) · Nov 3, 2026 · Earnings
Beat — AFFO $0.82 vs ~$0.78 consensus; FY26 guide midpoint $3.29 vs $3.24 prior
Omega’s third-quarter earnings beat estimates, while new investments and operator transitions lift 2026 guidance to $3.28-$3.30 AFFO per share.
Omega is in the middle of a deliberate shift from a mostly triple-net healthcare REIT toward a broader platform that also owns operating exposure through RIDEA structures, while using its balance sheet and operator relationships to expand in U.S. senior housing and U.K. care homes. That strategy was already underway before this release, so the news is mainly about execution and scale rather than a new direction.
The quarter cleared the available earnings bar. AFFO per diluted share was $0.82 versus roughly $0.78 in the published consensus, while FAD per share rose to $0.78 from $0.75 a year earlier. The comparison is favorable even after Omega issued 4.7 million shares during the quarter, which increased the diluted share base.
| Q3 2026 | Q3 2025 | Consensus / prior guide | |
|---|---|---|---|
| AFFO per diluted share (AFFO reconciliation) | $0.82 | $0.79 | ~$0.78 consensus |
| FAD per diluted share (Highlights) | $0.78 | $0.75 | |
| NOI (NOI Reconciliation) | $331.7M | $310.3M | |
| FY26 AFFO guide (2026 Guidance Increased) | $3.28-$3.30 | $3.22-$3.26 prior | |
| Operator EBITDAR coverage (Operator Census and Coverage) | 1.67x | 1.57x |
The more important change is the higher earnings base for the rest of 2026. Omega lifted its AFFO outlook midpoint by five cents, from $3.24 to $3.29 per share, after incorporating the recent investment activity, the completed Genesis resolution, and the Florida portfolio transition. That is a genuine improvement to the near-term operating story, not merely a reaffirmation.
Growth has accelerated sharply beyond the reported quarter. Omega completed $181.7 million of third-quarter investments and another $945.5 million from October 1 through the release date, led by an $845.7 million U.K. mortgage loan at an initial 8.72% interest rate. This materially advances the company’s capital deployment story, although the large mortgage transaction was funded with cash, recycled repayments, and revolver borrowings rather than being fully equity-funded.
Portfolio execution also improved the quality of several problem areas. The PACS transition replaces the prior Florida operator with a new master-lease counterparty and raises first-year contractual rent by $26.1 million, while the Genesis bankruptcy sale preserved Omega’s lease and returned $149.5 million of loan balances. Those outcomes reduce two operator-specific uncertainties that had been part of the standing story. 〔0〕
The trade-off is that growth is becoming more operationally and financially complex. Omega paid a $90 million lease termination fee for the PACS transition, issued $234 million of stock during the quarter, and is using its revolver to help fund the large U.K. mortgage. The company also recorded an $11.4 million impairment and $59.9 million of acquisition, merger, and transition costs, so GAAP net income understates the core operating momentum but also shows the cost of pursuing this expansion.
Bottom line: This is a clearly stronger-than-expected quarter, but the bigger signal is that Omega is converting its investment pipeline into a higher 2026 earnings outlook and cleaner operator roster. The story has advanced meaningfully, though the next phase depends on integrating a much larger RIDEA and U.K. investment footprint without eroding the balance-sheet advantage that enabled it.
November 4 earnings call; Runwood purchase option after regulatory approvals
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!